Unless the context otherwise requires, references to “New Abraxis,” “Abraxis
BioScience,” “Abraxis,” “we,” “us” and “our” refer to Abraxis BioScience, Inc.
(formerly New Abraxis, Inc.) and its subsidiaries, including our operating
subsidiary Abraxis BioScience, LLC (which we sometimes refer to as New Abraxis,
LLC); references to “Old Abraxis” refer to Abraxis BioScience, Inc. (formerly
American Pharmaceuticals, Inc.) prior to the separation; references to “New APP”
refer to APP Pharmaceuticals, Inc. and its subsidiaries, including its operating
subsidiary APP Pharmaceuticals Partners, LLC (which we sometimes refer to as New
APP LLC); and references to the “distribution,” “separation” or “spin-off” refer
to the transactions in which we separated from Old Abraxis and became an
independent publicly-traded company.  ...